Nutex Health (NASDAQ:NUTX) Shares Down 17.8% – Should You Sell?

Nutex Health Inc. (NASDAQ:NUTX)’s share price was down 17.8% during mid-day trading on Tuesday . The stock traded as low as $107.32 and last traded at $112.7530. Approximately 189,083 shares traded hands during trading, an increase of 28% from the average daily volume of 148,263 shares. The stock had previously closed at $137.21.

Wall Street Analysts Forecast Growth

NUTX has been the subject of several recent analyst reports. Wall Street Zen downgraded shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, October 18th. Maxim Group set a $205.00 target price on Nutex Health and gave the stock a “buy” rating in a research report on Tuesday, August 26th. Finally, Weiss Ratings upgraded Nutex Health from a “sell (d)” rating to a “hold (c)” rating in a research note on Tuesday. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $252.50.

Nutex Health Stock Performance

The stock’s 50 day moving average price is $112.16 and its two-hundred day moving average price is $113.50. The company has a current ratio of 2.27, a quick ratio of 2.26 and a debt-to-equity ratio of 1.02. The firm has a market capitalization of $797.72 million, a price-to-earnings ratio of 9.49 and a beta of -0.23.

Institutional Investors Weigh In On Nutex Health

Hedge funds have recently modified their holdings of the company. PharVision Advisers LLC acquired a new position in shares of Nutex Health in the third quarter valued at approximately $420,000. Quarry LP acquired a new stake in shares of Nutex Health during the third quarter worth $610,000. Millennium Management LLC grew its position in shares of Nutex Health by 191.1% in the third quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock valued at $9,650,000 after purchasing an additional 61,308 shares during the period. Bank of America Corp DE increased its stake in Nutex Health by 197.3% in the third quarter. Bank of America Corp DE now owns 11,045 shares of the company’s stock valued at $1,141,000 after purchasing an additional 7,330 shares during the last quarter. Finally, Topline Capital Management LLC lifted its position in Nutex Health by 80.0% during the third quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock worth $57,505,000 after buying an additional 247,436 shares during the period. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.